Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
Campylobacter infections
MeSH D002169 - campylobacter infections
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D016905:
Gram-negative bacterial infections
29 Companies
14 Drugs
$
Success rate
D002169:
Campylobacter infections
116 Companies
18 Drugs
$
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
0
%
0/1
Phase 2
100
%
2/2
Phase 3
80
%
8/10
Approved:
8
Overall Success rate:
0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Abbott Biotherapeutics
Erythromycin lactobionate
Allergan
Ciprofloxacin
,
Tetracycline
1
2
3
4
5
6
...
8
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use